BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as high as $0.02. BIOLASE shares last traded at $0.01, with a volume of 71,617 shares traded.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of BIOLASE in a research note on Saturday. They set a “sell” rating on the stock.
Read Our Latest Stock Analysis on BIOLASE
BIOLASE Stock Performance
BIOLASE Company Profile
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Featured Stories
- Five stocks we like better than BIOLASE
- What Are Treasury Bonds?
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- Dividend Capture Strategy: What You Need to Know
- Disney 2025 Shareholders: Major Updates for Investors
- Buy P&G Now, Before It Sets A New All-Time High
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.
